urovestВестник урологииUrology Herald2308-6424Rostov State Medical University10.21886/2308-6424-2023-11-1-134-142urovest-678Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWS ARTICLEПрименение обогащённой тромбоцитами плазмы (PRP) в урологической практикеThe use of platelet-rich plasma (PRP) in urologyhttps://orcid.org/0000-0003-2767-7153ПоповС. В.PopovS. V.

Сергей Валерьевич Попов — доктор медицинских наук, профессор; главный врач, руководитель городского центра эндоскопической урологии и новых технологий;

профессор кафедры урологии,

г. Санкт-Петербург

Sergey V. Popov — M.D., Dr.Sc. (Med), Full Prof.; Chief Medical Officer, Head, Municipal Centre of Endoscopic Urology and New Technologies;

Prof., Dept. of Urology,

St. Petersburg

doc.popov@gmail.comhttps://orcid.org/0000-0001-5566-9789ОрловИ. Н.OrlovI. N.

Игорь Николаевич Орлов — кандидат медицинских наук; заместитель главного врача по медицинской части;

ассистент кафедры урологии,

г. Санкт-Петербург

Igor N. Orlov — M.D., Cand.Sc.(Med); Deputy Chief Medical Officer for Medical;

Assist.Prof., Dept. of Urology,

St. Petersburg

doc.orlov@gmail.comhttps://orcid.org/0000-0002-5040-5546ТопузовТ. М.TopuzovT. M.

Тимур Марленович Топузов — кандидат медицинских наук; заведующий отделением урологии №1 городского центра эндоскопической урологии и новых технологий,

г. Санкт-Петербург

Timur M. Topuzov — M.D., Cand.Sc. (Med); Head, Urology Division No.1, Municipal Centre of Endoscopic Urology and New Technologies,

 

ttopuzov@gmail.comhttps://orcid.org/0000-0003-0118-9194ГореликМ. Л.GorelikM. L.

Максим Леонидович Горелик — клинический ординатор отделения урологии №1 городского центра эндоскопической урологии и новых технологий, 

г. Санкт-Петербург

Maksim L. Gorelik — Resident, Urology Division No.1, Municipal Centre of Endoscopic Urology and New Technologies, 

 

doc.gorelik@gmail.comhttps://orcid.org/0000-0002-3723-8157ПерфильевМ. А.Perfil’yevM. A.

Марк Артурович Перфильев - клинический ординатор отделения урологии №1 городского центра эндоскопической урологии и новых технологий,

г. Санкт-Петербург

Mark A. Perfil’yev — Resident, Urology Division No.1, St. Petersburg of Endoscopic Urology and New Technologies, 

 

perfilevmark@outlook.comhttps://orcid.org/0000-0001-5336-8245КотловМ. А.KotlovM. A.

Михаил Анатольевич Котлов — студент,

г. Санкт-Петербург

Mikhail A. Kotlov — Student, 

St. Petersburg

kotlovm2013@yandex.ruКлиническая больница Святителя Луки; Военно-медицинская академия им. С. М. КироваРоссияSt. Luke St. Petersburg Clinical Hospital; Kirov Military Medical AcademyRussian FederationКлиническая больница Святителя Луки; Северо-Западный государственный медицинский университет им. И. И. МечниковаРоссияSt. Luke St. Petersburg Clinical Hospital; Mechnikov North-Western State Medical UniversityRussian FederationКлиническая больница Святителя ЛукиРоссияSt. Luke St. Petersburg Clinical HospitalRussian FederationКлиническая больница Святителя Луки; Северо-Западный государственный медицинский университет им. И. И. МечниковаРоссияSt. Luke St. Petersburg Clinical Hospital; Mechnikov North-Western State Medical UniversityRussian Federation202308042023111134142Copyright © Попов С.В., Орлов И.Н., Топузов Т.М., Горелик М.Л., Перфильев М.А., Котлов М.А., 20232023Попов С.В., Орлов И.Н., Топузов Т.М., Горелик М.Л., Перфильев М.А., Котлов М.А.Popov S.V., Orlov I.N., Topuzov T.M., Gorelik M.L., Perfil’yev M.A., Kotlov M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.urovest.ru/jour/article/view/678

Одной из наиболее распространённых и практически реализуемых методик плазмотерапии является применение обогащённой тромбоцитами плазмы (Platelet-rich plasma — PRP). За счёт высокого содержания в её составе ростовых факторов, цитокинов, хемокинов открывается широкий терапевтический диапазон использования данной методики в различных областях медицины. Особенно выделяется свойство PRP индуцировать регенерацию тканей, что активно применяется для лечения широкого спектра урологических заболеваний. Целью данного обзора является освещение накопленного материала по теме применения аутологичных биоматериалов на основе крови в урологии. Данный обзор подчёркивает имеющуюся острую необходимость в дальнейшем изучении перспективы применения аутоплазменных технологий в более крупных и многоцентровых исследованиях. 

Platelet-rich plasma (PRP) is one of the most common and practicable plasma-therapy techniques. The wide therapeutic range for the use of this technique in various medical fields is due to its high content of growth factors, cytokines, and chemokines. The property of PRP to induce tissue regeneration is particularly highlighted, which is used actively for the treatment of a broad range of urological diseases. The review aimed to highlight the accumulated material on the topic of the use of autologous biomaterials based on blood in urology. This article highlights the urgent need for further study of the prospects for the use of autoplasma technologies in wide multicenter studies. 

обогащённая тромбоцитами плазмаобогащённый тромбоцитами фибринстриктура уретрыэректильная дисфункциястрессовое недержание мочигипоспадияplatelet rich plasmaplatelet rich fibrinurethral strictureerectile dysfunctionPeyronie’s diseasestress urinary incontinencehypospadiasReferencesGigante A, Del Torto M, Manzotti S, Cianforlini M, Busilacchi A, Davidson PA, Greco F, Mattioli-Belmonte M. Platelet rich fibrin matrix effects on skeletal muscle lesions: an experimental study. J Biol Regul Homeost Agents. 2012;26(3):475-84. PMID: 23034267Gigante A, Del Torto M, Manzotti S, Cianforlini M, Busilacchi A, Davidson PA, Greco F, Mattioli-Belmonte M. Platelet rich fibrin matrix effects on skeletal muscle lesions: an experimental study. J Biol Regul Homeost Agents. 2012;26(3):475-84. PMID: 23034267Kushida S, Kakudo N, Morimoto N, Hara T, Ogawa T, Mitsui T, Kusumoto K. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs. 2014;17(2):186-92. DOI: 10.1007/s10047-014-0761-5Kushida S, Kakudo N, Morimoto N, Hara T, Ogawa T, Mitsui T, Kusumoto K. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs. 2014;17(2):186-92. DOI: 10.1007/s10047-014-0761-5Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2014;16(1):204. DOI: 10.1186/ar4493Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2014;16(1):204. DOI: 10.1186/ar4493Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2008;1(3-4):165-74. DOI: 10.1007/s12178-008-9032-5Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2008;1(3-4):165-74. DOI: 10.1007/s12178-008-9032-5Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721-30. DOI: 10.1038/nrrheum.2013.141Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721-30. DOI: 10.1038/nrrheum.2013.141Jiritano F, Serraino GF, Cristodoro L, Renzulli A. Ventricular assist device abdominal driveline infection: treatment with platelet-rich plasma. J Thorac Cardiovasc Surg. 2013;145(6):e69-70. DOI: 10.1016/j.jtcvs.2013.02.072Jiritano F, Serraino GF, Cristodoro L, Renzulli A. Ventricular assist device abdominal driveline infection: treatment with platelet-rich plasma. J Thorac Cardiovasc Surg. 2013;145(6):e69-70. DOI: 10.1016/j.jtcvs.2013.02.072Marck RE, Middelkoop E, Breederveld RS. Considerations on the use of platelet-rich plasma, specifically for burn treatment. J Burn Care Res. 2014;35(3):219-27. DOI: 10.1097/BCR.0b013e31829b334eMarck RE, Middelkoop E, Breederveld RS. Considerations on the use of platelet-rich plasma, specifically for burn treatment. J Burn Care Res. 2014;35(3):219-27. DOI: 10.1097/BCR.0b013e31829b334eSchiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg. 2014;40(9):1010-9. DOI: 10.1097/01.DSS.0000452629.76339.2bSchiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg. 2014;40(9):1010-9. DOI: 10.1097/01.DSS.0000452629.76339.2bZhou B, Ren J, Ding C, Wu Y, Chen J, Wang G, Gu G, Li J. Protection of colonic anastomosis with platelet-rich plasma gel in the open abdomen. Injury. 2014;45(5):864-8. DOI: 10.1016/j.injury.2014.01.018Zhou B, Ren J, Ding C, Wu Y, Chen J, Wang G, Gu G, Li J. Protection of colonic anastomosis with platelet-rich plasma gel in the open abdomen. Injury. 2014;45(5):864-8. DOI: 10.1016/j.injury.2014.01.018Galliera E, Corsi MM, Banfi G. Platelet rich plasma therapy: inflammatory molecules involved in tissue healing. J Biol Regul Homeost Agents. 2012;26(2 Suppl 1):35S-42S. PMID: 23648197Galliera E, Corsi MM, Banfi G. Platelet rich plasma therapy: inflammatory molecules involved in tissue healing. J Biol Regul Homeost Agents. 2012;26(2 Suppl 1):35S-42S. PMID: 23648197Randelli P, Randelli F, Ragone V, Menon A, D'Ambrosi R, Cucchi D, Cabitza P, Banfi G. Regenerative medicine in rotator cuff injuries. Biomed Res Int. 2014;2014:129515. DOI: 10.1155/2014/129515Randelli P, Randelli F, Ragone V, Menon A, D'Ambrosi R, Cucchi D, Cabitza P, Banfi G. Regenerative medicine in rotator cuff injuries. Biomed Res Int. 2014;2014:129515. DOI: 10.1155/2014/129515Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008;13:3532-48. DOI: 10.2741/2947Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008;13:3532-48. DOI: 10.2741/2947Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835-70. DOI: 10.1152/physrev.2003.83.3.835Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835-70. DOI: 10.1152/physrev.2003.83.3.835Chatterjee US, Mandal MK, Basu S, Das R, Majhi T. Comparative study of dartos fascia and tunica vaginalis pedicle wrap for the tubularized incised plate in primary hypospadias repair. BJU Int. 2004;94(7):1102-4. DOI: 10.1111/j.1464-410X.2004.05111.xChatterjee US, Mandal MK, Basu S, Das R, Majhi T. Comparative study of dartos fascia and tunica vaginalis pedicle wrap for the tubularized incised plate in primary hypospadias repair. BJU Int. 2004;94(7):1102-4. DOI: 10.1111/j.1464-410X.2004.05111.xSoygur T, Arikan N, Zumrutbas AE, Gulpinar O. Snodgrass hypospadias repair with ventral based dartos flap in combination with mucosal collars. Eur Urol. 2005;47(6):879- 84; discussion 884. DOI: 10.1016/j.eururo.2005.02.022Soygur T, Arikan N, Zumrutbas AE, Gulpinar O. Snodgrass hypospadias repair with ventral based dartos flap in combination with mucosal collars. Eur Urol. 2005;47(6):879- 84; discussion 884. DOI: 10.1016/j.eururo.2005.02.022Mahmoud AY, Gouda S, Gamaan I, Baky Fahmy MA. Autologous platelet-rich plasma covering urethroplasty versus dartos flap in distal hypospadias repair: A prospective randomized study. Int J Urol. 2019;26(4):475-480. DOI: 10.1111/iju.13912Mahmoud AY, Gouda S, Gamaan I, Baky Fahmy MA. Autologous platelet-rich plasma covering urethroplasty versus dartos flap in distal hypospadias repair: A prospective randomized study. Int J Urol. 2019;26(4):475-480. DOI: 10.1111/iju.13912Antoniades HN, Williams LT. Human platelet-derived growth factor: structure and function. Fed Proc. 1983;42(9):2630-4. PMID: 6303866Antoniades HN, Williams LT. Human platelet-derived growth factor: structure and function. Fed Proc. 1983;42(9):2630-4. PMID: 6303866Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002;70(12):6524-33. DOI: 10.1128/IAI.70.12.6524-6533.2002Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002;70(12):6524-33. DOI: 10.1128/IAI.70.12.6524-6533.2002Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55(11):1294-9. DOI: 10.1016/s0278-2391(97)90187-7Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55(11):1294-9. DOI: 10.1016/s0278-2391(97)90187-7Braccini F, Tardivet L, Dohan Ehrenfest DM. Place des facteurs de croissance (Platelet-Rich Fibrin de Choukroun) dans la chirurgie de l'oreille moyenne: résultats préliminaires [The relevance of Choukroun's PlateletRich Fibrin (PRF) during middle ear surgery: preliminary results]. Rev Laryngol Otol Rhinol (Bord). 2009;130(3):175-80. (In French). PMID: 20345074Braccini F, Tardivet L, Dohan Ehrenfest DM. Place des facteurs de croissance (Platelet-Rich Fibrin de Choukroun) dans la chirurgie de l'oreille moyenne: résultats préliminaires [The relevance of Choukroun's PlateletRich Fibrin (PRF) during middle ear surgery: preliminary results]. Rev Laryngol Otol Rhinol (Bord). 2009;130(3):175-80. (In French). PMID: 20345074Mishra A, Woodall J Jr, Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med. 2009;28(1):113-25. DOI: 10.1016/j.csm.2008.08.007Mishra A, Woodall J Jr, Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med. 2009;28(1):113-25. DOI: 10.1016/j.csm.2008.08.007Scarcia M, Maselli FP, Cardo G, Ludovico GM. The use of autologous platelet rich plasma gel in bulbar and penile buccal mucosa urethroplasty: Preliminary report of our first series. Arch Ital Urol Androl. 2016;88(4):274-278. DOI: 10.4081/aiua.2016.4.274Scarcia M, Maselli FP, Cardo G, Ludovico GM. The use of autologous platelet rich plasma gel in bulbar and penile buccal mucosa urethroplasty: Preliminary report of our first series. Arch Ital Urol Androl. 2016;88(4):274-278. DOI: 10.4081/aiua.2016.4.274Gül M, Altıntaş E, Kaynar M, Buğday MS, Göktaş S. The predictive value of platelet to lymphocyte and neutrophil to lymphocyte ratio in determining urethral stricture after transurethral resection of prostate. Turk J Urol. 2017;43(3):325-329. DOI: 10.5152/tud.2017.14478Gül M, Altıntaş E, Kaynar M, Buğday MS, Göktaş S. The predictive value of platelet to lymphocyte and neutrophil to lymphocyte ratio in determining urethral stricture after transurethral resection of prostate. Turk J Urol. 2017;43(3):325-329. DOI: 10.5152/tud.2017.14478Rothan HA, Djordjevic I, Bahrani H, Paydar M, Ibrahim F, Abd Rahmanh N, Yusof R. Three-dimensional culture environment increases the efficacy of platelet rich plasma releasate in prompting skin fibroblast differentiation and extracellular matrix formation. Int J Med Sci. 2014;11(10):1029-38. DOI: 10.7150/ijms.8895Rothan HA, Djordjevic I, Bahrani H, Paydar M, Ibrahim F, Abd Rahmanh N, Yusof R. Three-dimensional culture environment increases the efficacy of platelet rich plasma releasate in prompting skin fibroblast differentiation and extracellular matrix formation. Int J Med Sci. 2014;11(10):1029-38. DOI: 10.7150/ijms.8895Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331(19):1286-92. DOI: 10.1056/NEJM199411103311907Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331(19):1286-92. DOI: 10.1056/NEJM199411103311907Sangkum P, Gokce A, Tan RB, Bouljihad M, Kim H, Mandava SH, Saleem SN, Lasker GF, Yafi FA, Abd Elmageed ZY, Moparty K, Sikka SC, Abdel-Mageed AB, Hellstrom WJ. Transforming Growth Factor-β1 Induced Urethral Fibrosis in a Rat Model. J Urol. 2015;194(3):820-7. DOI: 10.1016/j.juro.2015.02.014Sangkum P, Gokce A, Tan RB, Bouljihad M, Kim H, Mandava SH, Saleem SN, Lasker GF, Yafi FA, Abd Elmageed ZY, Moparty K, Sikka SC, Abdel-Mageed AB, Hellstrom WJ. Transforming Growth Factor-β1 Induced Urethral Fibrosis in a Rat Model. J Urol. 2015;194(3):820-7. DOI: 10.1016/j.juro.2015.02.014Rezaei M, Badiei R, Badiei R. The effect of platelet-rich plasma injection on post-internal urethrotomy stricture recurrence. World J Urol. 2019;37(9):1959-1964. DOI: 10.1007/s00345-018-2597-8Rezaei M, Badiei R, Badiei R. The effect of platelet-rich plasma injection on post-internal urethrotomy stricture recurrence. World J Urol. 2019;37(9):1959-1964. DOI: 10.1007/s00345-018-2597-8Ирицян М.М, Котов С.В., Клименко А.А. Применение плазмы, обогащенной тромбоцитами при уретропластике с целью профилактики повторного рецидива стриктуры уретры. Кардиоваскулярная терапия и профилактика. 2021;20(S1):36-37. eLIBRARY ID: 45556754; EDN: XMOKDHIricjan M.M, Kotov S.V., Klimenko A.A. Primenenie plazmy, obogashhennoj trombocitami pri uretroplastike s cel'ju profilaktiki povtornogo recidiva striktury uretry. Cardiovascular therapy and prevention. 2021;20(S1):36-37. (In Russian). eLIBRARY ID: 45556754; EDN: XMOKDHМедведев В.Л., Опольский А.М., Коган М.И. Сравнение клинической эффективности комплексного лечения пузырно-влагалищных свищей с применением аутоплазмы, обогащенной тромбоцитами и стандартного подхода к фистулопластике. Экспериментальная и клиническая урология. 2019;(2):158-163. DOI: 10.29188/2222-8543-2019-11-2-158-162.Medvedev V.L., Opolsky M.A., Kogan M.I. Clinical effectiveness of complex treatment vesicovaginal fistula using of the platelet reach autoplasma, compared to standard approach to fistuloplasty. Experimental and Сlinical Urology. 2019;(2):158-163. (In Russian). DOI: 10.29188/2222-8543-2019-11-2-158-162.Jhang JF, Wu SY, Lin TY, Kuo HC. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. Low Urin Tract Symptoms. 2019;11(2):O42-O47. DOI: 10.1111/luts.12212Jhang JF, Wu SY, Lin TY, Kuo HC. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. Low Urin Tract Symptoms. 2019;11(2):O42-O47. DOI: 10.1111/luts.12212Чалый М.Е., Григорян В.А., Епифанова М.В., Краснов А.О. Эффективность интракавернозного введения аутоплазмы, обогащенной тромбоцитами, в лечении эректильной дисфункции. Урология. 2015;(4):76-9. PMID: 26665770ME, Grigorjan VA, Epifanova MV, Krasnov AO. [The effectiveness of intracavernous autologous platelet-rich plasma in the treatment of erectile dysfunction]. Urologiia. 2015;(4):76-9. (In Russian). PMID: 26665770Глыбочко П.В., Чалый М.Е., Епифанова М.В., Ахвледиани Н.Д., Краснов А.О. Применение аутоплазмы, обогащенной тромбоцитарными факторами роста, в лечении эректильной дисфункции. Урология. 2015;(1):100-3. PMID: 26094397Glybochko PV, Chaly ME, Yepifanova MV, Akhvlediani ND, Krasnov AO. [Application of autoplasma enriched with platelet derived growth factor in the treatment of erectile dysfunction]. Urologiia. 2015;(1):100-3. (In Russian). PMID: 26094397Епифанова М.В., Чалый М.Е., Краснов А.О. Исследование механизмов действия факторов роста в аутоплазме, обогащенной тромбоцитами, применяемой для лечения эректильной дисфункции. Урология. 2017;(4):46-48. DOI: 10.18565/urol.2017.4.46-48Epifanova M.V., Chalyi M.E., Krasnov A.O. Investigation of mechanisms of action of growth factors of autologous platelet-rich plasma used to treat erectile dysfunction. Urologiia. 2017;(4):46-48. (In Russian). DOI: 10.18565/urol.2017.4.46-48Banno JJ, Kinnick TR, Roy L, Perito P, Antonini G, Banno D. 146 The Efficacy of Platelet-Rich Plasma (PRP) as a Supplemental Therapy for the Treatment of Erectile Dysfunction (ED): Initial Outcomes. The Journal of Sexual Medicine. 2017;14(2):e59–e60. DOI: 10.1016/j.jsxm.2016.12.134Banno JJ, Kinnick TR, Roy L, Perito P, Antonini G, Banno D. 146 The Efficacy of Platelet-Rich Plasma (PRP) as a Supplemental Therapy for the Treatment of Erectile Dysfunction (ED): Initial Outcomes. The Journal of Sexual Medicine. 2017;14(2):e59–e60. DOI: 10.1016/j.jsxm.2016.12.134Alkhayal S, Lourdes M. 320 Corporeal rejuvenation with platelet rich plasma as a treatment for erectile dysfunction. The Journal of Sexual Medicine. 2018;15(7):S254. DOI: 10.1016/j.jsxm.2018.04.283Alkhayal S, Lourdes M. 320 Corporeal rejuvenation with platelet rich plasma as a treatment for erectile dysfunction. The Journal of Sexual Medicine. 2018;15(7):S254. DOI: 10.1016/j.jsxm.2018.04.283Matz EL, Pearlman AM, Terlecki RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 2018;59(1):61-65. DOI: 10.4111/icu.2018.59.1.61Matz EL, Pearlman AM, Terlecki RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 2018;59(1):61-65. DOI: 10.4111/icu.2018.59.1.61

The authors declare that there are no conflicts of interest present.